FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
- Country
- Spain
- Type
- Beneficiary
- Website
- www.cnio.es
- Grants received
- 91
Funding record
- 91 grants on record
- €54,891,460.51 awarded in total
- 2007–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- Horizon Europe Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
34 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- EUROPEAN MOLECULAR BIOLOGY LABORATORY
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- KAROLINSKA INSTITUTET
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- ISTITUTO EUROPEO DI ONCOLOGIA SRL
- STICHTING RADBOUD UNIVERSITEIT
Calls from this organisation
No published calls from this organisation.
Grants received
- PUBLIC ENGAGEMENT IN RESEARCH INFRASTRUCTURES FOR MISSION CANCER: MANAGING COMPLEXITY OF EMERGING TECHNOLOGIES
- Targeting intracelular RANKL in breast cancer
- Metabolic control of cell growth by mTOR in health and disease: a multi-disciplinary training
- NUTRIENT FLUCTUATIONS AND THE INTEGRATIVE STRESS RESPONSE AS METABOLIC CELL FATE DETERMINANTS IN B CELL LYMPHOMA
- Targeting R2TP/TTT/WAC/mTOR complex in ovarian cancer.
- Integrating longitudinal multi-modal profiling of metastatic breast cancer patients for high-definition oncology
- Researchers and citizen creating together a better future
- Co-option of host circadian rhythms in cancer
- Accelerating datafication for support of EU health priorities, greening of biobanks and integrated approach to “One Health”
- GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD
- Targeting RANK receptor as a novel therapeutic strategy in triple negative breast cancer
- Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases
- PANcreatic CAncer Initial Detection via liquid biopsy
- From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
- The CD44-RANK-AKT Crosstalk in Breast Cancer and Stemness
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.